Medicare Enrolled
Dr. Shwetha Anand, M.D
Endocrinology · San Leandro, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anand
Dr. Shwetha Anand is an endocrinology specialist in San Leandro, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 1,206 Medicare services across 889 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anand received a total of $11,213 from 51 pharmaceutical and/or device companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 39% volume in CA
$11,213 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,206
Medicare services
Top 39% in CA for endocrinology
889
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
377 | $74 | $369 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $110 | $340 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
120 | $10 | $54 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
109 | $147 | $460 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
91 | $8 | $17 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
84 | $51 | $244 |
| New patient office visit, complex (60-74 min) | 50 | $170 | $567 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $128 | $420 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
40 | $32 | $119 |
| Blood glucose test using reagent strip A test that measures the level of sugar in the blood using a chemical reagent strip. |
35 | $5 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
30 | $8 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $78 | $237 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,213
Total received (2018-2024)
Avg $1,602/year across 7 years
Top 18% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
599
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,213 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,424
2023
$1,326
2022
$868
2021
$1,032
2020
$1,199
2019
$2,356
2018
$3,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$196
Lilly USA, LLC
$129
ABBVIE INC.
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$73
Amgen Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$69
Coherus Biosciences Inc.
$62
AstraZeneca Pharmaceuticals LP
$62
Dexcom, Inc.
$58
Astellas Pharma US Inc
$57
Kyowa Kirin, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$55
PFIZER INC.
$44
ADC Therapeutics America, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$38
SANOFI-AVENTIS U.S. LLC
$36
Alexion Pharmaceuticals, Inc.
$33
Janssen Biotech, Inc.
$29
Amneal Pharmaceuticals LLC
$25
Medtronic, Inc.
$23
BETA BIONICS, INC.
$23
Xeris Pharmaceuticals, Inc.
$23
PROGENICS PHARMACEUTICALS, INC.
$21
Azurity Pharmaceuticals, Inc.
$21
BeiGene USA, Inc.
$20
Genentech USA, Inc.
$20
Tandem Diabetes Care, Inc.
$18
Abbott Laboratories
$14
Novo Nordisk Inc
$14
Radius Health, Inc.
$13
Top 3 companies account for 28.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,420
AstraZeneca Pharmaceuticals LP
$1,296
Lilly USA, LLC
$1,178
Boehringer Ingelheim Pharmaceuticals, Inc.
$941
Janssen Pharmaceuticals, Inc
$826
Merck Sharp & Dohme Corporation
$536
SANOFI-AVENTIS U.S. LLC
$506
Amgen Inc.
$320
Corcept Therapeutics
$305
Medtronic MiniMed, Inc.
$289
Radius Health, Inc.
$286
Merck Sharp & Dohme LLC
$283
Amarin Pharma Inc.
$231
Janssen Biotech, Inc.
$226
Abbott Laboratories
$213
Bayer Healthcare Pharmaceuticals Inc.
$189
Mannkind Corporation
$186
Insulet Corporation
$173
Alexion Pharmaceuticals, Inc.
$155
MannKind Corporation
$150
Regeneron Healthcare Solutions, Inc.
$128
Medtronic, Inc.
$125
Dexcom, Inc.
$98
Coherus Biosciences Inc.
$91
GlaxoSmithKline, LLC.
$86
Genentech USA, Inc.
$80
ABBVIE INC.
$79
Shire North American Group Inc
$73
PFIZER INC.
$67
Bayer HealthCare Pharmaceuticals Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$60
Astellas Pharma US Inc
$57
Kyowa Kirin, Inc.
$56
Pharmacosmos Therapeutics Inc.
$46
ADC Therapeutics America, Inc.
$43
Pharmacyclics LLC, An AbbVie Company
$40
Tandem Diabetes Care, Inc.
$29
Amneal Pharmaceuticals LLC
$25
BETA BIONICS, INC.
$23
Xeris Pharmaceuticals, Inc.
$23
Tactile Systems Technology Inc
$22
Daiichi Sankyo Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$21
Azurity Pharmaceuticals, Inc.
$21
BeiGene USA, Inc.
$20
Hikma Pharmaceuticals USA
$20
AbbVie, Inc.
$20
iRhythm Technologies, Inc.
$18
CeQur Corporation
$18
SANOFI PASTEUR INC.
$17
LifeScan, Inc.
$12
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVASTIN · Alecensa · BAQSIMI · BLENREP · BREZTRI · BRUKINSA · BYDUREON · CeQur Simplicity · Crysvita · DARZALEX · Dexcom G6 Transmitter · EVENITY · Enbrel · Enhertu · FARXIGA · FLUBLOK QUADRIVALENT · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flexitouch Plus · FreeStyle Libre blood glucose Flash Monitoring System · GILOTRIF · GLYXAMBI · HUMULIN · HUMULIN R 500 · ICLUSIG · IMBRUVICA · INVOKANA · Imbruvica · InPen · Itovebi · JANUVIA · JARDIANCE · JAYPIRCA · KEYTRUDA · Kerendia · Korlym · Kyprolis · LANTUS · LIBTAYO · LUMAKRAS · LYNPARZA · MINIMED 780G · MONOFERRIC · MOUNJARO · Macrilen · Minimed 630G · Minimed 670G System · Mitigare · NATPARA · NATPARA (PARATHYROID HORMONE) · NINLARO · Nubeqa · Omnipod · OneTouch · Otezla · Ozempic · PAXLOVID · PRALUENT · PREVNAR 20 · PYLARIFY · Perjeta · Prolia · RECORLEV · RYBELSUS · RYBREVANT · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYMBICORT · SYNTHROID · Saxenda · Strensiq · Synthroid · TAGRISSO · TALTZ · TECVAYLI · TOUJEO · TRADJENTA · TRIJARDY XR · TRULICITY · TZIELD · Tresiba · Tymlos · ULTOMIRIS · Udenyca · VERZENIO · VIVIMUSTA · Vascepa · Veozah · Victoza · Vitrakvi · Wegovy · XARELTO · ZIO Patch · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
144
Per 100K population
8.7
County median income
$126,240
Nearest hospital
WILLOW ROCK CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anand is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anand experienced with telephone medical discussion, 21-30 minutes?
Based on Medicare claims data, Dr. Anand performed 377 telephone medical discussion, 21-30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $11,213 from 51 companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other endocrinologists in San Leandro?
Dr. Anand's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in San Leandro
Browse endocrinologists in San Leandro ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology